Industry-Supported Symposium
Maria Dall'Era, MD
Director
UCSF
Corte Madera, California, United States
Disclosure information not submitted.
Richard Furie, MD
Chief of the Division of Rheumatology
Northwell
Manhasset, NY, United States
Disclosure information not submitted.
Please note: This session is not eligible for CME Credits through ACR.
This session will not be recorded for on-demand.
Join the faculty for a lively and engaging discussion on the management of lupus nephritis. This will include the rationale for targeting B cells, presentation of the latest clinical data, new guidelines from ACR and EULAR, and how clinicians are incorporating B-cell targeting treatments into therapy for patients with lupus nephritis. Developed and offered by Paradigm Medical Communications, LLC. and supported by Genentech. Not an official program of the ACR. Physician Accreditation Statement
Paradigm Medical Communications, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physician Credit Designation Statement
Paradigm Medical Communications, LLC designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.